Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Visceral LeishmaniosisHIV-infection/Aids
Interventions
DRUG

Pentamidine

Pentamidine isethionate 300 mg for one vial for intramuscular or intravenous route(1 mg of pentamidine isethionate is equivalent to 0.57 mg of pentamidine base)

Trial Locations (3)

Unknown

Abdurafi Health Center/Médecins Sans Frontières, Abdurafi

Kahsay Abera Hospital, Humera

Leismania Research and Treatment Centre, University of Gondar Hospital, Gonder

All Listed Sponsors
collaborator

Addis Ababa University

OTHER

collaborator

University of Gondar

OTHER

collaborator

Tigray Regional Health Bureau, Tigray Region

UNKNOWN

collaborator

Amhara Regional Health Bureau, Amhara Region

UNKNOWN

collaborator

Medecins Sans Frontieres, Netherlands

OTHER

collaborator

Leishmania East Africa Platform (LEAP)

UNKNOWN

collaborator

Drugs for Neglected Diseases

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT01360762 - Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study | Biotech Hunter | Biotech Hunter